Latest in News & Research
UV Exposure Continues to Be Linked to Increased Melanoma Incidence in Those With Fair Skin
Studies on sunburn from last 20 years show positive significant odds ratios ranging from 1.23 to 8.48
Melanoma Incidence, Mortality Declining in Those Aged 30 to 49 Years
Melanoma incidence decreased for those aged 20 to 29, 30 to 39, 40 to 49 years; decline in melanoma mortality seen for those aged...
Skin Care Product Use by Children Tied to Phthalates/Replacement Metabolites
SCP use associated with urinary phthalate/replacement metabolites among young children
LAUNCH ALERT: FDA Expands Approval of Klisyri for Broader Actinic Keratosis Treatment
The expanded indication increases the treatment area on the face and scalp from 25 cm2 to 100 cm2
Link Between n-3 LCPUFA, Eczema Varies by Maternal COX1 Genotype
Risk for AD was lower in the n-3 LCPUFA versus placebo group among mothers with the TT genotype
Prevalence, Odds of Skin Cancer, Melanoma Increased for Veterans
Prevalence and odds of any skin cancer, melanoma, and psoriasis diagnosis higher compared with nonveterans
Metformin Eases Symptoms in Central Centrifugal Cicatricial Alopecia
Low-dose metformin linked to symptomatic improvement and modulation of gene expression in study involving 12 Black women
Dietary Vitamin E May Be Protective Against Atopic Dermatitis
Vitamin C, retinol, and carotene are not causally tied to atopic dermatitis
People With Xylazine Wounds Face Barriers to Seeking Wound Care
Of those seeking medical care for xylazine wounds, 74 percent reported health care stigma, 58 percent inadequate pain and withdrawal management
Residual Tumor Common in Patients Undergoing Mohs for Basal, Squamous Cell Cancers
Most patients with BCC, SCC have residual tumor at time of MMS, including in some clinically appearing tumor-free after biopsy
Platelet-Rich Plasma, Tranexamic Acid + Microneedling Beneficial for Melasma
Both platelet-rich plasma and tranexamic acid combined with microneedling improved melasma in split-face study
Childhood Obesity Tied to Pediatric Immune-Mediated Skin Diseases
Weight gain may increase atopic dermatitis risk, while weight loss may lower the risk
Congo Says First Vaccines to Fight Mpox Arriving Next Week
Collagen Peptide Beverage Beneficial for Skin Health in Young Women
Significant improvements seen in skin hydration, visual radiance and smoothness, and reduction in transepidermal water loss
Urban-Rural Health Disparities Persist in Skin Cancer
Higher odds of skin cancer seen for rural non-Hispanic Whites, Blacks, Hispanics, other race non-Hispanics, and Asians
Smoking Cessation Linked to Lower Risk for Hidradenitis Suppurativa
HS risk lower for smoking quitters, those who maintained cessation status, and never smokers versus sustained smokers
LAUNCH ALERT: Positive Results Released from LEVEL UP Trial Comparing Upadacitinib and Dupilumab for Atopic Dermatitis
Upadacitinib outperforms dupilumab in achieving superior efficacy for atopic dermatitis
Skin of Color Has More Adverse Events From Sclerotherapy
Postinflammatory hyperpigmentation seen more often versus lighter skin tones
LAUNCH ALERT: Nemluvio Gains FDA Approval for Prurigo Nodularis
Galderma’s nemolizumab is the first monoclonal antibody to specifically target IL-31 signaling
FDA Approves Nemluvio for Prurigo Nodularis
Clinical trials show significant benefits for itch, skin nodules, and sleep disturbance versus placebo
Survival Plateaus After Three Years of ICI Treatment of Advanced Melanoma
Findings show decrease in survival from three years of treatment to five years for patients treated with ICIs in clinical practice
Withdrawal of Baricitinib Results in Loss of Benefit in Severe Alopecia
80 percent of patients with withdrawal of treatment lose benefit; most recapture benefit after retreatment
Gene Expression Signature Predicts Immune-Related Adverse Events in Melanoma Patients
Gene expression signature predicts irAEs in melanoma patients treated with ipilimumab/nivolumab
24 of 1238